Advanced Filters
noise

uterine-disorders Clinical Trials

A listing of uterine-disorders medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 571 clinical trials
J Jun Guan, MD

Sentinel Lymph Node Sampling for Patients With Middle-high Risk Endometrial Cancer Confined to the Uterus

Aim To investigate the effect of sentinel lymph node (SLN) sampling on the prognosis of patients with middle-high risk endometrial cancer obviously confined to the uterus before surgery.

18 - 80 years of age Female Phase N/A
N Nadav Michaan, MD

Virtual Reality During Conization of Cervix Uterus Under Local Anesthesia

To evaluate the effectiveness of virtual reality glasses as a distraction technique in the management of acute pain and anxiety during conization of cervix uterus under local anesthesia

18 - 80 years of age Female Phase N/A
J Jane Littleton, AG-ACNP, FNP

Uterus Transplantation to Treat Infertility

This research study will use uterus transplantation to treat uterine factor infertility, also known as the inability to bear children due to not having a uterus. The purpose of this study is to enable women seeking genetically-related children and the childbearing experience to experience pregnancy and birth a child. In …

18 - 38 years of age Female Phase 2/3
M Mats Brännström

Uterus Transplantation by Robotics - Gothenburg III

Robotic assisted organ procurement and robotic assisted transplantation in live donor uterus transplantation

18 - 38 years of age Female Phase N/A

Uterus Transplantation Procedure From a Live Donor

Absolut uterine factor, meaning the absence of uterus, represents a cause for sterility without the possibility of a present treatment. The uterine factor affects millions of women and may be due to congenital problems, such as the Muller anomalies (Mayer Rockitansky Syndrome) or acquired by previous hysterectomy or intrauterine adhesions …

18 - 65 years of age Female Phase N/A
L Ludivine DION

Transplantation of Uterus for Uterine infertiLIty From Living Donor or Deceased Donor

Patients with absolute Uterine Factor Infertility (AUFI) are infertile due to the absence of a uterus. The absence of a uterus can be either iatrogenic (hysterectomy for gynecological pathology such as cancer or for obstetric pathology such as postpartum hemorrhage with hysterectomy for hemostasis), or congenital with utero-vaginal agenesis including …

18 - 100 years of age Female Phase N/A
A Ahmed Taha, Professor

The Efficacy of a Temporary Sub-Placental Uterine Tourniquet in Minimizing Intraoperative Blood Loss in Management of Placenta Accreta Spectrum Disorder by a Retrograde Cesarean Hysterectomy (Bladder Last)

This trial will study the role of a temporary tourniquet around the uterus to reduce blood loss in management of patients with abnormally implanted placenta who will undergo removal of the uterus.

20 - 40 years of age Female Phase N/A
C Christina Bliss Barsness

HPV Self-Sampling in Somali Women

This study plans to assess the effect of implementing HPV self-sampling in primary care on uptake of cervical cancer screening in 30-65 year old Somali women who are due for cervical cancer screening.

30 - 65 years of age Female Phase N/A
L Lovisa Bergengren, MD, PhD

SMS-based Summons in Cervical Screening

Prevention of cervical cancer with cervical screening (gynecological cell test) is one of the most successful screening activities in medicine. In Sweden screening has taken place since the 1960s and prevented tens of thousands of women from having cervical cancer. There are strong reasons why it is especially important to …

33 - 75 years of age Female Phase N/A

MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)

The purpose of this study is to determine the safety, tolerability, and preliminary efficacy of pembrolizumab/vibostolimab co-formulation (MK-7684A) with or without other anticancer therapies in participants with selected advanced solid tumors. The primary hypothesis is that pembrolizumab/vibostolimab co-formulation is superior to pembrolizumab alone in terms of objective response rate or …

18 - 100 years of age Both Phase 2

Rewrite in simple language using AI